Blockbuster weight-loss and diabetes medicines sales surge despite cost barriers
Sales of weight loss medicines like Ozempic and Mounjaro have sky-rocketed in South Africa in recent years, although they remain too expensive for most people who might benefit from the jabs. In the first article of this Spotlight special series, Catherine Tomlinson tracks their remarkable rise and assesses when they will become more widely available here.
